Pharmacoeconomics
Why Patient Engagement Matters in HCV
Last week we published a literature review of economic models published on new hepatitis C…
Pharmaceutical Market Strategies
Last week we published a literature review of economic models published on new hepatitis C…
Recently, I had the opportunity to work with two strong pharmacoeconomics researchers (Daniel Mullins and…
A guest post by Mike Paulden, Health Economist from the University of Alberta, and Dr.…